<span>Creating meaningful interoperability in patient electronic health records</span>
September 5, 2023

Creating meaningful interoperability in patient electronic health records

My background in the electronic health record (EHR) space ranges from implementing EHR technology into physician practices to building reporting solutions in support of the Centers for Medicare and Medicaid Services’ “meaningful use.” This was a main source for the influx of physicians adopting EHRs and creating and sharing structured, reportable data. Since then, our industry has made massive investments in interoperability solutions, and we have seen many initiatives attempting to connect health systems. However, as I engage with healthcare providers and executives, I see a continued challenge in defining how we deliver data and achieve meaningful interoperability. To improve the experience, we should look for ways to increase connectivity, accessibility and ease of use. 
Read more »

Gary M. Stuhlmiller, PhD

Gary M. Stuhlmiller, PhD, serves as a technical director in the division of DNA identity testing at Labcorp. He joined Labcorp following 11 years on the faculty in the Department of Surgery at Duke University Medical Center, where he was technical director of the Melanoma Immunobiology Laboratory. Dr. Stuhlmiller holds a BS in Microbiology from Cornell University and a PhD in Immunology from Duke University. Dr.

Minghui Li, PhD, MLS (ASCP), S(ACHI)

Dr. Minghui Li earned his PhD in cellular and molecular biology from the University of Nevada, Reno, and his master’s degree in clinical laboratory science from Augusta University, Augusta, GA. Dr Li joined the DNA Identification laboratory after completing his HLA lab director- in-training at Virginia Commonwealth University’s HLA laboratory. His current responsibilities include human leukocyte antigen (HLA) testing for disease associations, pharmacogenomics and histocompatibility support for transplant centers and bone marrow registries. Dr.

Vera C Lattier, PhD

Dr. Vera Lattier received her PhD in molecular and cellular biology from Oregon State University, Corvallis, and her master’s degree in pathology from National Taiwan University, Taipei, Taiwan. She completed post-doctoral training at the National Cancer Institute, National Institute of Health, Bethesda, MD. Before joining Labcorp, she worked as a research and development scientist in drug discovery and assay development. She has discovered several genetic biomarkers associated to disease prognosis and published numerous scientific articles in international journals.